DSM Sinochem Pharmaceuticals (DSP) has been renamed to Centrient Pharmaceuticals, following the recent change of ownership to private-equity investors Bain Capital. In late June, DSM and Sinochem agreed to sell their DSP 50-50 joint venture to Bain Capital, and the transaction was completed on 31 October.
As well as reflecting the company’s “key contribution to modern healthcare”, Centrient said that the new name “marks the next...




